Literature DB >> 2955817

The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.

S Sunami, A Fuse, B Simizu, M Eguchi, Y Hayashi, K Sugita, S Nakazawa, Y Okimoto, T Sato, H Nakajima.   

Abstract

The c-sis gene expression in leukemia cells from a patient with acute megakaryoblastic leukemia and Down's syndrome was studied. The leukemia blasts were identified as megakaryoblasts by the platelet peroxidase reaction and the reactivity against antiplatelet monoclonal antibodies. Leukemia cells obtained from peripheral blood or bone marrow specimens before and after initiation of chemotherapy were analyzed for c-sis gene expression by the RNA-DNA dot blot hybridization. Although the level varied, the mRNA of the c-sis gene was detected in all megakaryoblastic leukemia cells obtained at different clinical stages. The c-sis mRNA level in cells obtained after relapse was higher than that obtained before the initiation of therapy. The 25S c-sis mRNA was detected in a megakaryoblastic leukemia cell line established from this patient. The role of the expression of the c-sis gene in acute megakaryoblastic leukemia cells is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 2955817

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

Review 1.  Pathogenesis of idiopathic myelofibrosis: role of growth factors.

Authors:  J T Reilly
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV.

Authors:  Esther Merlini; Alessandro Cozzi-Lepri; Antonella Castagna; Andrea Costantini; Sergio Lo Caputo; Stefania Carrara; Eugenia Quiros-Roldan; Maria A Ursitti; Andrea Antinori; Antonella D'Arminio Monforte; Giulia Marchetti
Journal:  BMC Infect Dis       Date:  2021-06-12       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.